These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2104438)

  • 1. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities].
    Lopaciuk S; Misiak A; Wisławski S; Ciesielski L; Korzycki J; Judkiewicz L; Lewandowski K; Tokarz A; Kłoczko J; Bielawiec M
    Pol Tyg Lek; 1990 Nov 19-26; 45(47-48):949-52. PubMed ID: 2104438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
    Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
    Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity].
    Lopaciuk S; Meissner AJ; Ziemski JM; Tokarz A; Psuja P; Zawilska K; Głowiński S; Wołczyński Z; Czestochowska E; Tymiński W
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):704-7. PubMed ID: 1669137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin treatment. Comparison between intravenous and subcutaneous administration].
    Krähenbühl B; Simon CA; Bouvier CA; Schinas P; Hopf MA; Cochet B
    Schweiz Med Wochenschr; 1979 Sep; 109(36):1322-5. PubMed ID: 504973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.
    Bounameaux H; Ehringer H; Hulting J; Rasche H; Rapold HJ; Zultak M
    Thromb Haemost; 1997 Sep; 78(3):997-1002. PubMed ID: 9308743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin in deep venous thrombosis of the leg--effectiveness and safety].
    Gatterer E; Stöllberger C; Slany J; Stöberl C; Jaksch J
    Wien Klin Wochenschr; 1988 Sep; 100(18):601-5. PubMed ID: 3188535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
    Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of deep vein thrombosis of the lower extremity in pregnancy.
    Aburahma AF; Bastug DF; Tiley EH; Killmer SM; Boland JP
    W V Med J; 1993 Oct; 89(10):445-7. PubMed ID: 8266682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of thrombosis with conventional heparin].
    Harenberg J
    Z Kardiol; 1993; 82 Suppl 2():71-5. PubMed ID: 8328212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
    Charbonnier BA; Fiessinger JN; Banga JD; Wenzel E; d'Azemar P; Sagnard L
    Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
    Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Soria J; Soria C; Camez A; Mirshahi MC; Bassand JP
    Thromb Haemost; 1994 May; 71(5):558-62. PubMed ID: 8091380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cost-effectiveness of administering heparin subcutaneously or intravenously for the treatment of deep vein thrombosis.
    Barber ND; Hoffmeyer UK
    Ann R Coll Surg Engl; 1993 Nov; 75(6):430-3. PubMed ID: 8285546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.